Valneva SE: New Order from the U.S. Department of Defense for Vaccine Against JE!

Valneva SE is a biotechnology company focused on the development and marketing of vaccines against infectious diseases. Unlike large pharmaceutical companies, Valneva concentrates on niche markets, including Japanese Encephalitis and the Chikungunya virus. This opens up potential for expansion into regions with a high risk of tropical infectious diseases. An increasing demand for travel vaccination serves as a potential growth driver. The product portfolio mainly consists of IXIARO and IXCHIQ (VLA1553). IXIARO is the only FDA-approved vaccine...